Abstract Basal metabolic rate (BMR) represents the minimum energy expenditure required to sustain life at rest, accounting for 60–70% of total daily energy turnover in sedentary humans. Historically viewed as a static, species-specific constant, BMR is now recognized as a dynamic phenotype shaped by body composition, endocrine status, mitochondrial efficiency, and recent advances in high-throughput metabolic phenotyping. This review synthesizes breakthroughs from the past three years, including the development of wearable indirect calorimetry, single-cell mitochondrial respirometry, and large-scale genome-wide association studies (GWAS) that have identified novel BMR-modulating loci. We further discuss the emerging role of BMR as a predictive biomarker for metabolic disease, its paradoxical decline during caloric restriction, and the potential of chrono-nutrition and cold-adapted thermogenesis to modulate BMR without adverse cardiovascular effects. Finally, we outline future directions integrating multi-omics, artificial intelligence, and real-time metabolic feedback to enable personalized BMR-based interventions for obesity, sarcopenia, and healthy aging.

1. Introduction: redefining BMR beyond the Harris–Benedict equation For over a century, BMR estimation relied on predictive equations (Harris–Benedict, Mifflin-St Jeor) that approximate BMR from age, sex, height, and weight. However, these formulas explain only ~60–70% of inter-individual variance, leaving a substantial “metabolic gap” attributable to genetic background, gut microbiota composition, thyroid hormone sensitivity, and skeletal muscle oxidative capacity. Recent work bySpeakman et al. (2023, Nature Metabolism)using a cohort of 6,400 adults with doubly labeled water and whole-room calorimetry demonstrated that fat-free mass (FFM) explains 78% of BMR variance, but the residual variance is highly heritable (h² ≈ 0.32). This finding catalyzed a shift toward high-resolution phenotyping of BMR as a quantitative trait with clinical utility.

2. Technological breakthroughs in BMR measurement The gold standard for BMR remains indirect calorimetry under strict conditions (fasting, supine, thermoneutral, awake). Yet, its clinical adoption is limited by cost and time. Three recent innovations address this gap:

3. Genetic and epigenetic control of BMR: new loci and regulatory networks The largest GWAS to date on BMR (n = 210,000, UK Biobank + Metabochip) identified 47 independent loci, 19 of which are novel (Yengo et al., 2024, Nature Genetics). Key findings include:

4. BMR and metabolic adaptation: the “metabolic slowdown” paradox One of the most debated topics is whether BMR declines more than predicted by weight loss alone. The landmarkCALERIEtrial (Comprehensive Assessment of Long-term Effects of Reducing Intake of Energy) showed that 25% caloric restriction for 2 years reduced BMR by ~120 kcal/day beyond what FFM loss predicts. Recent follow-up analysis (Redman et al., 2025, Nature Aging) using repeated whole-room calorimetry revealed that this “metabolic adaptation” persists after 1 year of weight maintenance and correlates with decreased circulating triiodothyronine (T3) and increased skeletal muscle mitochondrial coupling efficiency (P/O ratio). Importantly, this adaptation is not uniform: individuals with high baseline BMR (>1,900 kcal/day) exhibit 3-fold greater adaptation than those with low baseline BMR, suggesting a set-point mechanism that protects against further energy deficit.

5. Therapeutic modulation of BMR: cold, chrono-nutrition, and pharmacological targets

6. BMR in precision medicine and longevity: from prediction to intervention BMR is emerging as a central node in multi-omics risk scores. A 2025 study (Franks et al., Diabetes) integrated BMR (measured via wearable calorimetry), serum metabolomics (kynurenine, branched-chain amino acids), and polygenic risk scores for type 2 diabetes. The addition of BMR improved reclassification of prediabetes risk by 22% (net reclassification index), outperforming traditional adiposity indices. In aging research, a longitudinal cohort of 5,000 adults aged 50–90 showed that a BMR decline of >5% per decade (independent of FFM) is associated with a 1.8-fold increased risk of frailty and all-cause mortality (Ferrucci lab, 2025, Journals of Gerontology). This has prompted the development of “metabolic resilience” interventions combining resistance training (to preserve FFM) with low-dose thyroid hormone analogs (to maintain BMR) under continuous glucose and ketone monitoring.

7. Future outlook: closing the loop between measurement and modulation The next frontier is the development of closed-loop systems that continuously measure BMR